The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $40.00 Call had some of the highest implied ...

Hologic (HOLX) announced that its Affirm Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...

Being part of this prestigious index is often viewed as a bullish indicator, but these stocks also boast strong fundamentals.